Aurobindo Pharma arm incorporates new wholly owned subsidiary in Malaysia
Advertisement
Aurobindo Pharma has announced that Helix Healthcare B.V., a wholly owned subsidiary of the Company, has incorporated a new wholly owned subsidiary in Malaysia by the name of Aurobindo Pharma (Malaysia) SDN. BHD.
The object of incorporation of this wholly owned subsidiary is to expand the Pharmaceutical Products business in Malaysia.
According to the disclosure on BSE, the Malaysian subsidiary was incorporated on September 17, 2025, with an initial share capital of RM 400,000 (approximately USD 100,000) divided into 400,000 shares of nominal value of RM 1.00 each.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.